Intracellular C-BDE-47 concentrations were calculated after background subtraction (same treatment without spheres) by a standard concentration curve and normalized to sphere volumes.
These results demonstrated that Y-27632 treatment increases sphere-forming activity.
Initially, the preparation was more or less monolithic in nature, however, following pre-treatment, small spheres or, in the case of pure enzyme, a fine powder could be observed on the surface.
Although adherent cells expressed low levels of myogenin (3,6% and 11,5%) after treatment (Figure 2C), sphere cultures showed much stronger upregulation of myogenin positivity (∼50%) (Figure 2D).
The induction of HEY1 expression is repressed by the expression of dnMAML or DAPT treatment in the sphere culture (B).
The failure of cisplatin + DEAB treatment to inhibit sphere formation led us to examine the drug-resistance properties of ALDH and CD44 at the transcript level.
Consistent with the in vivo limiting-dilution analyses, a subpopulation of NOTCH1 transformed mammary tumor cells grow in an in vitro tumorsphere assay and importantly, doxycycline treatment significantly reduces sphere number and size.
Treatment of MCF7 sphere cells with MitoVES homologues differing in the length of the aliphatic chain linking the tocopheryl succinyl group TPP+ group revealed that the short-chain homologues are inefficient in ROS generation and apoptosis induction (Fig. 6 E, F), pointing to CII as a target.
A higher concentration of spheres needed for treatment with lower activity per sphere, i.e., resin spheres, increases the absorbed dose non-uniformity within the liver parenchyma, competing with the increase in non-uniformity due to the higher activity per microsphere of glass spheres.
The treatment of the sphere-wall boundary condition is analyzed to avoid underestimating the friction of pebble near the wall.
